[Protein kinase C activation and diabetic complications].
Yamamoto-Honda
Ritsuko
R
The Institute for Adult Disease, Asahi Life Foundation.
Kadowaki
Takashi
T
D000804:Angiotensin II / Q000502:physiology; D000818:Animals; D048909:Diabetes Complications / Q000209:etiology*; D004075:Diglycerides / Q000378:metabolism; D004789:Enzyme Activation; D017127:Glycation End Products, Advanced / Q000096:biosynthesis; D006801:Humans; D006943:Hyperglycemia / Q000201:enzymology; D007527:Isoenzymes / Q000037:antagonists & inhibitors; D011108:Polymers / Q000378:metabolism; D011493:Protein Kinase C / Q000037:antagonists & inhibitors / Q000378:metabolism*; D017382:Reactive Oxygen Species
D004075:Diglycerides; D017127:Glycation End Products, Advanced; D007527:Isoenzymes; D011108:Polymers; D017382:Reactive Oxygen Species; C024617:polyol; D000804:Angiotensin II; D011493:Protein Kinase C